• All
  • Advisory
  • Blood Donations
  • Blood Testing
  • Pediatrics
  • Primary Care
  • Testosterone

  According to the American Urological Association, about two out of 10 men over age 60 have low testosterone. That number increases slightly, to three out of 10 men in their 70s and 80s. We get an idea of how high these numbers are, given the...

  Blood is a vital element in performing surgeries throughout the country, one which regularly sees a shortage. According to the American Red Cross, winter is one of the most difficult times of year to collect enough blood products to meet patient needs. This season, take...

  In previous blog posts, we discussed how frequently you should have a blood exam, and what to expect during a blood exam. In preparation for these tests, there are specific requirements to follow, one of which is fasting. Keep reading to learn how food can...

Affecting one in three adults in the United States, high blood pressure, or hypertension, is one of the leading causes of death. Despite being a high risk for heart disease and stroke, this condition is known for rarely presenting symptoms. Learn about the dangers of...

While most people are aware of blood exams, many still questions whether they should receive one – and if so, when? Even if you believe yourself to be in perfect health, a regular blood exam can reveal information that could require regular monitoring or lifestyle...

  Determining the status of your health can be difficult, but with today's technology it has become easier and faster. One of the most efficient ways to test a variety of concerns in one procedure is through blood exams. They can quickly ‒ and for the...

Having your blood drawn for a diagnostic or screening exam isn’t anyone’s favorite way to spend part of the day. If this will be your first time, you may feel anxious about what to expect. Medical procedures involving needles are a well-known fear to many,...

Publish date: June 7, 2018 By Christopher Palmer  Hematology News The Food and Drug Administration has approved methoxy polyethylene glycol-epoetin beta (Mircera) for the treatment of dialysis-related anemia in pediatric patients aged 5-17 years with chronic kidney disease whose hemoglobin had been stabilized with an erythropoiesis-stimulating agent (ESA). The approval for this long-acting...